Skipping Hormone Therapy in Low-Risk Early Breast Cancer

NCT07661927 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

700

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer (Early Breast Cancer)

Interventions

DRUG: Removing Endocrine Therapy

Sponsor

UNICANCER

Collaborators

[object Object]